Skip to main content
. 2021 Apr 7;12:623913. doi: 10.3389/fneur.2021.623913

Table 2.

Age-stratified analysis and sex-stratified analysis of 12 loci.

SNPs (candidate gene) Genotype, allele Age onset < 50 years Age onset 50 years Male Female
PD Control p1 OR (95%CI)1 PD Control p2 OR (95%CI)2 PD Control p3 OR (95%CI)3 PD Control p4 OR (95%CI)4
rs10748818 GG 7 28 0.370 71 26 0.132 44 27 0.126 34 27 0.524
(GBF1) GA 16 113 243 81 146 107 131 87
AA 23 106 167 81 110 104 80 83
G 30 169 0.766 0.931 (0.579–1.495) 385 133 0.117 1.219(0.952–1.562) 234 161 0.080 1.251(0.973–1.608) 181 141 0.222 1.190(0.900–1.572)
A 62 325 577 243 366 315 273 253
rs11950533 CC 24 119 0.034* 235 90 0.783 146 108 0.704 113 101 0.954
(C5orf24) CA 17 103 201 83 123 106 95 80
AA 5 25 45 15 31 24 19 16
C 65 341 0.757 1.080 (0.663–1.759) 671 263 0.944 0.991(0.764–1.285) 415 322 0.594 1.073(0.828–1.390) 321 282 0.781 0.959(0.712–1.291)
A 27 153 291 113 185 154 133 112
rs34025766 TT 38 188 - 385 148 0.418 240 190 - 183 146 -
(LCORL) AT 8 55 88 39 55 46 41 48
AA 0 4 8 1 5 2 3 3
T 84 431 0.274 1.535 (0.709–3.321) 858 335 0.961 1.010(0.689–1.481) 535 426 0.862 0.966(0.654–1.427) 407 340 0.133 1.375(0.907–2.086)
A 8 63 104 41 65 50 47 54
rs55961674 CC 36 190 - 380 143 0.568 239 185 - 177 148 -
(KPNA1) CT 8 55 95 41 57 49 46 47
TT 2 2 6 4 4 4 4 2
C 80 435 0.767 0.904 (0.465–1.758) 855 327 0.328 1.197(0.834–1.718) 535 419 0.558 1.120(0.767–1.634) 400 343 0.643 1.101(0.732–1.658)
T 12 59 107 49 65 57 54 51
rs61169879 CC 9 45 0.673 88 39 0.439 55 40 0.544 42 44 0.351
(BRIP1) CT 22 135 249 87 147 128 124 94
TT 15 67 144 62 98 70 61 59
C 40 225 0.714 0.920(0.587–1.440) 425 165 0.922 1.012(0.796–1.287) 257 208 0.776 0.965(0.757–1.231) 208 182 0.912 0.985(0.751–1.291)
T 52 269 537 211 343 268 246 212
rs666463 AA 42 229 0.978a 456 180 0.613 284 222 0.499 214 187 0.768
(DNAH17) AT 4 18 25 8 16 16 13 10
- - - - - - - - -
A 88 476 0.978a 0.832(0.275–2.517) 937 368 0.617 0.815(0.364–1.823) 584 460 0.505 1.270(0.628–2.566) 441 384 0.771 0.883(0.383–2.037)
T 4 18 25 8 16 16 13 10
rs75859381 TT 41 226 0.813a 426 169 - 267 219 0.240 200 176 -
(RPS12) CT 5 21 54 19 33 19 26 21
CC 0 0 1 0 0 0 1 0
T 87 473 0.818a 0.773(0.284–2.104) 906 357 0.583 0.861(0.504–1.470) 567 457 0.252 0.714(0.401–1.273) 426 373 0.602 0.857(0.478–1.534)
C 5 21 56 19 33 19 28 21
rs76116224 AA 45 242 1.000b 478 187 1.000a 296 236 0.899a 227 193 0.098a
(KCNS3) AT 1 5 3 1 4 2 0 4
- - - - - - - - -
A 91 489 1.000b 0.930(0.107–8.057) 959 375 1.000a 0.571(0.153–2.133) 596 474 0.899a 0.629(0.115–3.447) 454 390 0.099a 0.462(0.430–0.497)
T 1 5 3 1 4 2 0 4
rs76949143 TT 38 191 - 347 142 0.042* 217 184 0.241 168 149 -
(GS1-124K5·11) AT 7 51 128 39 78 48 57 42
AA 1 5 6 7 5 6 2 6
A 9 61 140 53 88 60 61 54
rs77351827 CC 46 247 - 481 188 - - 300 238 - - 227 197 - -
(CRLS1) C 92 494 - - 962 376 - - 600 476 - - 454 394 - -
rs7938782 AA 33 176 0.969 340 127 0.085 210 162 0.327 163 141 0.693
(RNF141) GA 12 64 131 51 84 66 59 49
GG 1 7 10 10 6 10 5 7
A 78 416 0.890 1.045(0.563–1.938) 811 305 0.159 1.250(0.916–1.707) 504 390 0.433 0.880(0.638–1.212) 385 331 0.751 1.062(0.732–1.540)
G 14 78 151 71 96 86 69 63
rs850738 AA 15 74 0.843 169 70 0.300 102 82 0.345 82 62 0.587
(FAM171A2) GA 24 127 224 93 140 121 108 99
GG 7 46 88 25 58 35 37 36
A 54 275 0.591 1.132(0.721–1.777) 562 233 0.235 0.862(0.675–1.101) 344 285 0.401 0.901(0.705–1.150) 272 223 0.329 1.146(0.872–1.507)
G 38 219 400 143 256 191 182 171
*

A two-tailed p < 0.05 was considered significant.

a

Continuous correction for Chi-square test when at least one cell has an expected value of less than 5.

b

Adjusted by Fisher's exact test when at least one cell has an expected value of < 1.

PD, Parkinson's disease; SNPs, single nucleotide polymorphisms; CI, confidence interval; OR, odds ratio. The bold means the P value < 0.05.